Demand the FDA Fast-Track Sernova’s Cell Pouch For Type One Diabetics


Demand the FDA Fast-Track Sernova’s Cell Pouch For Type One Diabetics
The Issue
Sign this petition to tell the FDA: People with Type 1 Diabetes deserve access to life-changing treatments NOW!
🚨 Why This Matters
Millions of people with Type 1 Diabetes (T1D) are forced to rely on insulin therapy to survive—a 100-year-old treatment that manages symptoms but does not cure the disease. Meanwhile, a groundbreaking solution already exists, but the FDA is stalling its approval.
Sernova’s Cell Pouch System is proving in clinical trials that it can restore natural insulin production in T1D patients. This means:
✅ No more insulin injections
✅ Better blood sugar control
✅ A real path toward a lasting cure
The only limitation right now is that patients must take immunosuppressants to protect the transplanted islet cells. But for many diabetics, that trade-off is worth it—because it means being free from insulin therapy.
We demand that the FDA give diabetics the right to choose this treatment instead of forcing us to wait years for a “perfect” cure.
🔥 The Facts: Why the FDA Must Act NOW
• The Cell Pouch is working – Patients in clinical trials are producing their own insulin again.
• No structural failures – The device is safely integrating with the body.
• Future improvements are coming – Sernova, in partnership with Evotec, is developing a scalable supply of lab-grown islet cells, with the goal of eventually making them immune-protected.
But instead of allowing diabetics access to a working solution, the FDA is slow-walking progress, forcing us to stay dependent on insulin therapy while they take their time.
🛑 The Double Standard
During the COVID-19 pandemic, the FDA rushed to approve experimental treatments and vaccines because they recognized the urgency of saving lives. So why aren’t they treating Type 1 Diabetes with the same urgency?
This disease:
⚠ Shortens lives
⚠ Causes life-threatening complications
⚠ Costs patients thousands every year
Yet, instead of moving quickly to provide relief, the FDA continues to delay access to a proven therapy.
💥 What We Demand
1️⃣ FDA Fast-Track Approval for Sernova’s Cell Pouch – Allow diabetics the choice to access this treatment now.
2️⃣ Accelerate Trials for Future Improvements – The next step is eliminating the need for immunosuppressants. The FDA must support these advancements instead of slowing them down.
3️⃣ Transparency in the Process – The public deserves to know why diabetics are being forced to wait.
Give Us the Right to Choose
We’re not asking the FDA for a favor—we’re demanding the right to access a treatment that could change lives. If some diabetics are willing to take immunosuppressants in exchange for freedom from insulin, why is the FDA preventing them from making that choice?
We will not wait any longer. Sign this petition and help us tell the FDA: Diabetics deserve options. Give us access to the Cell Pouch NOW!
1,336
The Issue
Sign this petition to tell the FDA: People with Type 1 Diabetes deserve access to life-changing treatments NOW!
🚨 Why This Matters
Millions of people with Type 1 Diabetes (T1D) are forced to rely on insulin therapy to survive—a 100-year-old treatment that manages symptoms but does not cure the disease. Meanwhile, a groundbreaking solution already exists, but the FDA is stalling its approval.
Sernova’s Cell Pouch System is proving in clinical trials that it can restore natural insulin production in T1D patients. This means:
✅ No more insulin injections
✅ Better blood sugar control
✅ A real path toward a lasting cure
The only limitation right now is that patients must take immunosuppressants to protect the transplanted islet cells. But for many diabetics, that trade-off is worth it—because it means being free from insulin therapy.
We demand that the FDA give diabetics the right to choose this treatment instead of forcing us to wait years for a “perfect” cure.
🔥 The Facts: Why the FDA Must Act NOW
• The Cell Pouch is working – Patients in clinical trials are producing their own insulin again.
• No structural failures – The device is safely integrating with the body.
• Future improvements are coming – Sernova, in partnership with Evotec, is developing a scalable supply of lab-grown islet cells, with the goal of eventually making them immune-protected.
But instead of allowing diabetics access to a working solution, the FDA is slow-walking progress, forcing us to stay dependent on insulin therapy while they take their time.
🛑 The Double Standard
During the COVID-19 pandemic, the FDA rushed to approve experimental treatments and vaccines because they recognized the urgency of saving lives. So why aren’t they treating Type 1 Diabetes with the same urgency?
This disease:
⚠ Shortens lives
⚠ Causes life-threatening complications
⚠ Costs patients thousands every year
Yet, instead of moving quickly to provide relief, the FDA continues to delay access to a proven therapy.
💥 What We Demand
1️⃣ FDA Fast-Track Approval for Sernova’s Cell Pouch – Allow diabetics the choice to access this treatment now.
2️⃣ Accelerate Trials for Future Improvements – The next step is eliminating the need for immunosuppressants. The FDA must support these advancements instead of slowing them down.
3️⃣ Transparency in the Process – The public deserves to know why diabetics are being forced to wait.
Give Us the Right to Choose
We’re not asking the FDA for a favor—we’re demanding the right to access a treatment that could change lives. If some diabetics are willing to take immunosuppressants in exchange for freedom from insulin, why is the FDA preventing them from making that choice?
We will not wait any longer. Sign this petition and help us tell the FDA: Diabetics deserve options. Give us access to the Cell Pouch NOW!
1,336
The Decision Makers
Supporter Voices
Share this petition
Petition created on March 7, 2025
